Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
XCancer
Omaha, Nebraska, United Statesxcancer.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
XCancer has led over twenty First-in-the-world clinical advancements in prostate cancer care—including landmark work with Ga‑68 PSMA PET imaging and Lu‑177 PSMA therapy—and provides rapid access to novel oncology clinical trials through its global research network. The company enables community centers to launch advanced studies within weeks.
- Therapeutic areas
- Oncology
- Modalities
- RadiopharmaceuticalSmall moleculeBiologicDevice/Imaging agent
- Industry
- Academic Hospital/University/Research
02
Partnerships
Innovative sponsors and CROs supporting multicenter oncology trials nationwide
Beyond the preview
Go deeper on XCancer.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on XCancer.